We advised the underwriters on the SPAC IPO and Nasdaq listing

Davis Polk advised the underwriters in connection with the initial public offering of 200,000,000 units of Summit Healthcare Acquisition Corp. for aggregate proceeds of $200 million. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant to purchase Class A ordinary share of Summit Healthcare Acquisition Corp. The Class A ordinary shares and warrants are listed on the Nasdaq Capital Market under the symbols “SMIH” and “SMIHW”, respectively

Summit Healthcare Acquisition Corp. is a special purpose acquisition company (SPAC) whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses or entities. Although Summit Healthcare Acquisition Corp. is not limited to a particular industry or geographic region for purposes of consummating a business combination, the company intends to focus on healthcare.

The Davis Polk corporate team included partner James C. Lin and registered foreign lawyers Xin (Sheen) Xu and Mendtuvshin (Mendee) Enkhtaivan. The tax team included counsel Alon Gurfinkel and associate Summer Xia. Counsel Marcie A. Goldstein provided FINRA advice. Members of the Davis Polk team are based in the Hong Kong, London and New York offices.

Copy link to share post